To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement. Secondary objectives: * Qualitative evaluation of indication as well as adherence to the test result. * Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).
Study Type
OBSERVATIONAL
Enrollment
770
The use of the BV test, ordered at the discretion of the treating physician
Sana Kliniken
Berlin, Germany
NOT_YET_RECRUITINGUniversitätsklinikum Bonn
Bonn, Germany
NOT_YET_RECRUITINGSaarland University
Homburg, Germany
RECRUITINGUniversitätsklinikum Würzburg
Antibiotics
Number of participants treated with antibiotics
Time frame: up to 30 days
Antibiotic duration
Length of antibiotic treatment per participant
Time frame: up to 30 days
Hospitalization
Number of participants admitted to the hospital
Time frame: up to 30 days
Complications
Rate of complications per participant
Time frame: up to 30 days
Tests
Rate of ancillary tests per participant
Time frame: up to 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Würzburg, Germany